# OnCo record epoetin-theta (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/epoetin-theta/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "epoetin-theta" ;
  schema:name "Epoetin theta"@en ;
  schema:alternateName "epoetin theta"@en, "Eporatio"@en, "Biopoin"@en, "Eporatio / Biopoin" ;
  schema:description "Epoetin theta is a made-to-order version of erythropoietin, the hormone that tells the marrow to make red blood cells. It is used to treat the anaemia of chemotherapy in people with non-myeloid cancers, sparing some transfusions."@en ;
  schema:url <https://onco.cc/drugs/epoetin-theta/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.ema.europa.eu/en/medicines/human/EPAR/eporatio>, <https://www.ema.europa.eu/en/medicines/human/EPAR/biopoin> ;
  onco:status "approved" ;
  onco:tag "ema-register", "supportive" ;
  onco:modality "Recombinant erythropoietin (erythropoiesis-stimulating agent)" ;
  onco:approval "EU 2009: Symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy; anaemia of chronic renal failure" ;
  onco:related <https://onco.cc/drugs/epoetin-alfa/>, <https://onco.cc/drugs/darbepoetin-alfa/> ;
  onco:technologies <https://onco.cc/technologies/transfusion-support/> ;
  onco:targets <https://onco.cc/targets/epor/> ;
  onco:companies <https://onco.cc/companies/teva/> .